Column Group

Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Column Group

Companies in the Column Group portfolio as of the September 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ngm Biopharmaceuticals (NGM) 36.8 $324M 15M 21.02
Tenaya Therapeutics 22.1 $194M NEW 9.4M 20.65
Oric Pharmaceuticals (ORIC) 11.3 $100M 4.8M 20.91
Revolution Medicines (RVMD) 10.5 $92M 3.3M 27.51
Surrozen 7.4 $66M NEW 9.2M 7.08
Effector Therapeutics 6.9 $61M NEW 4.3M 14.05
Rapt Therapeutics (RAPT) 5.0 $44M -63% 1.4M 31.05

Past Filings by Column Group

SEC 13F filings are viewable for Column Group going back to 2020